Literature DB >> 26588079

Posttraumatic Stress Disorder-Related Hospitalizations in the United States (2002-2011): Rates, Co-Occurring Illnesses, Suicidal Ideation/Self-Harm, and Hospital Charges.

Mark G Haviland1, Jim E Banta, Janet L Sonne, Peter Przekop.   

Abstract

The purpose of the present study was to evaluate posttraumatic stress disorder (PTSD)-related hospitalizations in the United States (2002-2011). Over this period, there were an estimated 1,477,944 hospitalizations (915,591 women) with either a primary (reason for hospitalization) or secondary PTSD diagnosis. Population-based hospitalization rates rose from 2002 to 2011; women in the age range of 20 to 44 years had the highest rates and the steepest rise. Most of the hospitalizations for men and women younger than 45 years had been assigned a primary diagnosis of mental illness (including PTSD). Mood and substance use disorders were among the most commonly co-occurring psychiatric diagnoses with PTSD. Suicidal ideation/suicide attempts declined with increasing age. The strongest predictor of this criterion was mood disorder, and its importance as a predictor increased as people aged. Total inflation-adjusted charges for all PTSD-related hospitalizations were $34.9 billion, with 36% being for hospitalizations where a mental illness (including PTSD) was the primary diagnosis.

Entities:  

Mesh:

Year:  2016        PMID: 26588079     DOI: 10.1097/NMD.0000000000000432

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  8 in total

1.  Dimensionality of DSM-5 posttraumatic stress disorder and its association with suicide attempts: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Chiung M Chen; Young-Hee Yoon; Thomas C Harford; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-04-11       Impact factor: 4.328

2.  Glucocorticoid-glucocorticoid receptor-HCN1 channels reduce neuronal excitability in dorsal hippocampal CA1 neurons.

Authors:  Jiwon Kim; Yun Lei; Xin-Yun Lu; Chung Sub Kim
Journal:  Mol Psychiatry       Date:  2022-07-15       Impact factor: 13.437

3.  Circulating insulin-like growth factor I modulates mood and is a biomarker of vulnerability to stress: from mouse to man.

Authors:  A Santi; M Bot; A Aleman; B W J H Penninx; I Torres Aleman
Journal:  Transl Psychiatry       Date:  2018-08-01       Impact factor: 6.222

Review 4.  Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.

Authors:  Allison A Feduccia; Lisa Jerome; Berra Yazar-Klosinski; Amy Emerson; Michael C Mithoefer; Rick Doblin
Journal:  Front Psychiatry       Date:  2019-09-12       Impact factor: 4.157

5.  Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial.

Authors:  Elliot Marseille; Jennifer M Mitchell; James G Kahn
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

6.  The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study.

Authors:  Anton L V Avanceña; James G Kahn; Elliot Marseille
Journal:  Clin Drug Investig       Date:  2022-03-01       Impact factor: 2.859

Review 7.  Progress in Personalized Psychiatric Therapy with the Example of Using Intranasal Oxytocin in PTSD Treatment.

Authors:  Sandra Szafoni; Magdalena Piegza
Journal:  J Pers Med       Date:  2022-06-29

8.  Associations Between Trauma, Sleep, and Cognitive Impairment Among Latino and Asian Older Adults.

Authors:  Altaf Saadi; Mario Cruz-Gonzalez; Andrew Hwang; Lauren Cohen; Margarita Alegria
Journal:  J Am Geriatr Soc       Date:  2021-01-05       Impact factor: 5.562

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.